Who Regulates Medical Devices in Costa Rica

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The competent authority for the regulation, registration, verification and control of biomedical equipment and materials (Equipo y Material Biomédico, EMB) in Costa Rica is the Ministry of Health (Ministerio de Salud), and its operating body is the Directorate for the Regulation of Products of Health Interest (Dirección de Regulación de Productos de Interés Sanitario, DRPIS). All applications for registration, renewal and post-registration changes must be filed electronically through the Regístrelo portal; offline submission is not permitted. Throughout RTCR 505:2022 the rights and obligations are assigned to the figure of the Ministerio de Salud, and this point directly determines that the counterparty for company appeals, objections and remedies is the Ministry of Health itself, not any individual directorate.

  • Ministerio de Salud is the sole legal counterparty for registration, verification, infringement findings and sanctions.
  • DRPIS is the operating directorate, identified through Costa Rica’s official WTO notification, not named in the main regulation.
  • Regístrelo is the statutory sole channel for registration, renewal and post-registration change applications.
  • Digital signatures must satisfy the Central Bank’s integrity, authenticity and temporal-validity guarantees.
  • National verification is carried out by the Ministry of Health or by inspectors it authorizes.
  • Authorizations for ionizing radiation sources are issued by the radiological protection directorate under Article 11.6.

2. Legal basis

The provisions below establish the institutional and procedural basis for the regulation of EMB in Costa Rica, from the approval of the main regulation to the operation of the Regístrelo portal and the powers of verification.

LevelInstrumentProvisionKey point
Technical regulationRTCR 505:2022 (Decreto Ejecutivo N° 43902-S, 2022-11-30)Article 1Purpose of the main regulation: to establish the requirements and procedures for the classification, registration, import and control of EMB
Technical regulationRTCR 505:2022Article 9EMB must first obtain the corresponding sanitary registration before being manufactured, imported, commercialized or distributed
Technical regulationRTCR 505:2022Article 10.1Registration, renewal and post-registration change applications must be processed through the Regístrelo portal platform
Technical regulationRTCR 505:2022Article 10.2Digital signatures must comply with the Central Bank standards for integrity, authenticity and temporal validity
Technical regulationRTCR 505:2022Article 22.1National verification is performed by the Ministry of Health or by inspectors (inspectores) it authorizes
Technical regulationRTCR 505:2022Article 11.6Authorization of ionizing radiation sources is issued by the Ministry of Health’s Directorate of Radiological Protection and Environmental Health
Administrative decreeDecreto Ejecutivo N° 37988-S (2013-10-03, La Gaceta N° 203, 2013-10-22)Full textRules on the operation and use of the Regístrelo portal
Approving decreeDecreto Ejecutivo N° 43902-SArticles 2 and 3Determination of infringements and application of sanctions in market surveillance, decided by the Ministry of Health

Additional institutional note: the identity of DRPIS as the responsible authority is recorded in Costa Rica’s official notification to the WTO under the Agreement on Technical Barriers to Trade (Ministerio de Salud, Dirección de Regulación de Productos de Interés Sanitario, telephone (+506) 2233-6922). The name of this directorate does not appear in the body of the main regulation itself, which consistently refers only to the Ministerio de Salud.

3. Expert insights

Insight one: the main regulation recognizes only one legal subject, the Ministry of Health, and DRPIS is an internal division of labour. Articles 1, 9, 14 and 22.1 of the main regulation, together with Articles 2 and 3 of the approving decree, vest the powers to approve registrations, to verify, to determine infringements and to impose sanctions entirely in the Ministerio de Salud. This means that the issuing body of a sanitary registration is the Ministry of Health, and the body that orders market withdrawal or cancellation is likewise the Ministry of Health. When a company designs its dispute-response pathway, the legal counterparty is the Ministry of Health; narrowing the communication channel to a particular technical office creates errors of subject matter in procedural documents. The functional position of DRPIS can be confirmed through the WTO notification, but it should not be presented as replacing the Ministry of Health in legal documents.

Insight two: Regístrelo is the legally mandated sole channel, not a recommended channel. The original wording of Article 10.1 reads “deben ser tramitados a través de la plataforma del portal “Regístrelo””, which is mandatory language. The same article anchors the procedure in DE 37988-S, meaning the portal’s operating rules carry the force of regulation. Article 10.2 further requires that all digital signatures satisfy the Central Bank’s triple guarantees of integrity, authenticity and temporal validity. The combined practical effect of these two provisions is that paper dossiers, scanned documents sent by e-mail, or electronic files generated through a company’s internal seal workflows do not constitute valid submissions.

Insight three: the verification subject is the Ministry of Health or its authorized inspectors, and the scope of authorization is written into the main regulation. Article 22.1 allows the Ministry of Health to authorize inspectores to perform verification. This is an authorization clause that is often overlooked: the personnel who arrive on site may not be career staff of the Ministry of Health, yet the legal consequences of their inspection acts are attributed to the Ministry of Health. When receiving an inspection, companies should verify the inspector’s authorization credentials and request a written record of the scope of the inspection, rather than relying solely on an identification badge.

Insight four: the authorization for ionizing radiation sources is the only prior licence in the main regulation that names a specific directorate, and that directorate is written in two different ways within the regulation. Article 11.6 assigns the authorization to the “Dirección de Protección Radiológica y Salud Ambiental” (Directorate of Radiological Protection and Environmental Health), while Articles 18.10.5 and 18.16.7 refer to the same function as “Dirección de Protección al Ambiente Humano”. The coexistence of two institutional names in the same regulation is a consistency issue in the text of the main regulation. The practical approach is to use the name in Article 11.6 in external correspondence, and to state in the submission materials the function indicated by both names, so that a formal review is not rejected over a name discrepancy.

4. Practical recommendations

  • At project start-up, register the Ministry of Health (Ministerio de Salud) uniformly as the recipient of official correspondence, deficiency notices and decision documents, and map it internally to DRPIS’s business window in your own workflow.
  • Before opening a Regístrelo portal account in Costa Rica, first obtain the digital signature certificate and confirm that the certificate meets the Central Bank’s temporal-validity guarantee requirements; do not substitute a scanned signature for a digital signature.
  • For products containing ionizing radiation sources (including software used to control or monitor such equipment), schedule the radiation source authorization as a parallel matter independent of the sanitary registration well in advance (Article 11.6, DE 24037-S).
  • Establish an inspection-response plan: verify the inspector’s authorization document, retain a copy of the inspection record, and relay the record to the in-country legal representative within 24 hours.
  • Before each submission, check the current versions of the main regulation and of DE 37988-S, as well as the form version numbers published by the Ministry of Health on the Regístrelo portal, and never reuse an outdated form.

5. Verification checklist

  • □ Confirm that the competent authority is the Ministerio de Salud and the operating body is DRPIS
  • □ Confirm that registration, renewal and change applications are all filed through the Regístrelo portal (Article 10.1)
  • □ Confirm that digital signatures meet the Central Bank integrity, authenticity and temporal-validity standards (Article 10.2)
  • □ Confirm that the verification subject is the Ministry of Health or its authorized inspectors (Article 22.1)
  • □ Confirm whether the product contains ionizing radiation sources and whether a parallel source authorization is required (Article 11.6)
  • □ Record the difference in directorate names between Articles 11.6 and 18.10.5 for formal-review inquiries
  • □ Check the current form version numbers on the Regístrelo portal

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Costa Rican market. Our team manages Ministry of Health (Ministerio de Salud) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail